James Simon, M.D., clinical professor of obstetrics and gynecology, was mentioned in an article in Healio's Endocrine Today on his study finding Flibanserin, a serotonin receptor 1A agonist/serotonin receptor 2A antagonist, safely and effectively improved the sexual interactions of naturally postmenopausal women diagnosed with hypoactive sexual desire disorder.
Healio - Serotonin Receptor Shows Promise in Hypoactive Sexual Desire Disorder
Latest News
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (GW MFA) is pleased to announce that Mohamad Koubeissi, MD, FAAN, FANA, FAES, professor of neurology, has been selected to serve as the chair of the Department of Neurology and…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Mandy K. Cohen, MD, MPH, will be the keynote speaker for the 2025 GW MD Graduation Celebration and Diploma Ceremony on May 18, 2025, in Lisner Auditorium.
Washington, D.C., leaders, joined representatives from Universal Health Services (UHS), the George Washington University School of Medicine and Health Sciences (GW SMHS) and The GW Medical Faculty Associates (GW MFA) April 10, as Mayor Muriel Bowser cut the ribbon on the first new hospital to open…